Business Context and Reporting Period
This Form 8-K Current Report was filed by Jaguar Health, Inc. on May 13, 2021, regarding the 2021 Annual Meeting of Stockholders. The report details the adjournment of the meeting originally called to order on May 13, 2021.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
The primary material event reported is the failure to achieve a quorum at the Annual Meeting on May 13, 2021. Consequently, the meeting was adjourned and rescheduled for June 11, 2021, at 8:30 a.m. Pacific Time. No changes were made to the proposals to be voted on by stockholders.
Outlook, Risks, and Management Commentary
- Management Action: The Company adjourned the meeting to allow additional time for stockholders to submit proxies to ensure a quorum is reached.
- Record Date: The record date for the Annual Meeting remains April 12, 2021.
- Stockholder Guidance: Stockholders who have already voted do not need to take further action unless they wish to change their vote.
- Documentation: The Company directs investors to the definitive proxy statement (Schedule 14A) filed on April 13, 2021, for details on the proposals.
Important Facts for Investors to Verify
- Confirm the rescheduled date and time for the Annual Meeting: June 11, 2021, at 8:30 a.m. Pacific Time.
- Verify the location of the reconvened meeting: 200 Pine Street, Suite 400, San Francisco, CA 94104.
- Review the definitive proxy statement filed on April 13, 2021, to understand the specific proposals pending a vote.
- Note that the press release announcing the adjournment (Exhibit 99.1) is furnished but not deemed "filed" under Section 18 of the Exchange Act.